What drug company makes PERJETA?
Genentech: Perjeta® (pertuzumab) – Information for Patients.
How long is a PERJETA infusion?
2.2 Recommended Doses and Schedules The initial dose of PERJETA is 840 mg administered as a 60-minute intravenous infusion, followed every 3 weeks by a dose of 420 mg administered as an intravenous infusion over 30 to 60 minutes.
How often is PERJETA given?
PERJETA is given every 3 weeks as an IV infusion When you begin treatment, your doctor will start PERJETA, Herceptin® (trastuzumab), and docetaxel at the same time, and may adjust the medicines in your treatment plan over time.
Are PERJETA and Herceptin given together?
PERJETA is given with another targeted treatment called Herceptin. Both treatments are designed to fight cancer cells that have too many HER2 receptors, but in different ways. Since normal cells also have HER2 receptors (just not as many), PERJETA and Herceptin can also affect healthy cells.
How expensive is Herceptin?
The sticker price on Perjeta is $5,900 a month, or about $71,000 a year, Genentech says. Herceptin’s price tag is $4,500 a month, or $54,000 a year. That’s $115,000 for a year’s worth of treatment. But the combo is likely to be used for longer than that, a Genetech spokesperson told FierceBiotech.
How common is hair loss with Perjeta?
Pertuzumab and trastuzumab do not usually cause people to lose their hair. Any hair loss caused by chemotherapy should be temporary and in most cases your hair will begin to grow back once your chemotherapy has ended.
Is Perjeta considered chemotherapy?
Drug Type: Perjeta™ is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. This medication is classified as an “antineoplastic agent and a monoclonal antibody”.
Is PERJETA considered chemotherapy?
Does PERJETA cause bone pain?
Some people being treated with Perjeta experience side effects such as muscle or joint pain, chills, and rash that should be immediately brought to the attention of the healthcare provider administering treatment.
Which is better Perjeta or Herceptin?
Herceptin Plus Perjeta Slightly Better for High-Risk, HER2-Positive Disease Than Herceptin Alone. Adding Perjeta to Herceptin and chemotherapy after surgery to treat early-stage, HER2-positive breast cancer slightly improves survival; women diagnosed with high-risk, HER2-positive, early-stage disease got more benefits.
Is Perjeta expensive?
Perjeta (generic name: pertuzumab) intravenous (IV) solution (420 mg per 14 milliliters) costs $5,534 if you are paying cash. This cost could exceed $99,000 over one year’s worth of treatment (given every 3 weeks) for 18 cycles. This is a discounted price based on using the Drugs.com price guide.
How much is Perjeta and Herceptin?
The sticker price on Perjeta is $5,900 a month, or about $71,000 a year, Genentech says. Herceptin’s price tag is $4,500 a month, or $54,000 a year. That’s $115,000 for a year’s worth of treatment.
Does perjeta cause joint pain?
Do you lose your hair with Perjeta?
Hair thinning or hair loss Pertuzumab and trastuzumab do not usually cause people to lose their hair. Any hair loss caused by chemotherapy should be temporary and in most cases your hair will begin to grow back once your chemotherapy has ended.
Does perjeta make you tired?
Some side effects may occur during the injection. Tell your caregiver right away if you feel weak, tired, or nauseated, or if you have a fast heartbeat, headache, fever, chills, muscle pain, or an unusual taste in your mouth.
How much does Perjeta cost?
Perjeta (generic name: pertuzumab) intravenous (IV) solution (420 mg per 14 milliliters) costs $5,534 if you are paying cash. This cost could exceed $99,000 over one year’s worth of treatment (given every 3 weeks) for 18 cycles.
What is Perjeta used to treat?
Perjeta is a HER2 inhibitor given by intravenous infusion, and is approved to treat early or metastatic breast cancer This is not all the information you need to know about Perjeta for safe and effective use. Review the full Perjeta information here, and discuss this information with your doctor or other health care provider.
What is the mechanism of action of Perjeta and Herceptin?
The mechanisms of action of Perjeta and Herceptin (trastuzumab) are believed to complement each other, as both bind to the HER2 receptor, but to different locations. The combination of Perjeta and Herceptin is thought to provide a more comprehensive, dual blockade of HER signalling pathways, thus preventing tumour cell growth and survival.